Gilead Pushes Court To Invalidate 2 Merck Drug Patents
Gilead Sciences Inc. urged a California federal judge Thursday to invalidate two Merck & Co Inc. patents on a hepatitis C drug, arguing that the patents fail to explain how the...To view the full article, register now.
Already a subscriber? Click here to view full article